CME in Minutes: Education in Rheumatology, Immunology, & Infectious Diseases
By Answers in CME
Listen to a podcast, please open Podcast Republic app. Available on Google Play Store and Apple App Store.
Image by Answers in CME
Category: Life Sciences
Open in Apple Podcasts
Open RSS feed
Open Website
Rate for this podcast
Subscribers: 0
Reviews: 0
Episodes: 30
Description
Get answers in 25 minutes or less from world-class experts and earn CME/CE credit with CME in Minutes: Education in Rheumatology, Immunology, and Infectious Diseases by Answers in CME. Benefit from digests of latest advancements, thoughtful case studies, and nuanced perspectives anytime, anywhere, and on any device. Inspiring and engaging programs designed for busy healthcare professionals to cover the diagnosis, treatment, follow-up, and clinical management of conditions from rheumatology, immunology, and infectious diseases. Earning your CME/CE credit has never been faster or easier. Visit the URL for each individual program to request continuing education credit or access the slides.
| Episode | Date |
|---|---|
|
Peter Lio, MD - Generative AI: Benefits for Your Practice, for Your Patients
|
Apr 05, 2024 |
|
Martin C. Mahoney, MD, PhD - Reducing the Burden of HPV-Related Cancers: Strategies for Improving HPV Vaccine Uptake in Males
|
Mar 29, 2024 |
|
Juliana M. Kling, MD, MPH - Improving Inclusive Care: Enhancing HPV Vaccine Uptake Among LGBTQ+ Individuals
|
Feb 28, 2024 |
|
John N. Allan, MD - Enhancing Patient Outcomes in Relapsed/Refractory Follicular Lymphoma: Recognizing the Role of Novel Bispecific Antibody–Based Therapies
|
Feb 14, 2024 |
|
Jonathan Barker, BSc, MB, BS, MD, FRCP - Novel Approved and Emerging IL-36 Receptor Inhibitors for the Treatment of GPP
|
Jan 26, 2024 |
|
Nicola A. Hanania, MD, MS - Enough: Targeting Eosinophilic Pathways With Biologics in Chronic Obstructive Pulmonary Disease
|
Jan 12, 2024 |
|
Michael Wechsler, MD - On the Case to Improve Outcomes in Uncontrolled Asthma: Best Practices to Enhance Clinical Care
|
Dec 29, 2023 |
|
Jennifer Hill, MD - Breathing New Air Into Improved Outcomes: Strategies to Optimize Care in Patients With Uncontrolled Asthma
|
Dec 05, 2023 |
|
Shawn Kwatra, MD - Itching for Relief: Exploring the Role of Novel Biologics in Prurigo Nodularis
|
Oct 06, 2023 |
|
Joshua Richter, MD / Saad Z. Usmani, MD, MBA, FACP - Optimizing Patient Outcomes in Relapsed/Refractory Multiple Myeloma: The Role of Novel BCMA-Targeted Bispecific Antibodies
|
Sep 19, 2023 |
|
Bradley Chipps, MD - Calling the Shots for Pediatric Asthma Control: Integrating Biologics Into the Treatment Plan to Enhance Outcomes
|
Aug 17, 2023 |
|
Tina Q. Tan, MD - Easing the RSV Burden in Infants: Looking Ahead to New Prevention Strategies
|
Jun 27, 2023 |
|
Gary W. Falk, MD, MS / Ikuo Hirano, MD - Enhancing Outcomes in Adults and Children With Eosinophilic Esophagitis by Targeting Type 2 Inflammation
|
Jun 08, 2023 |
|
Russell D. Cohen, MD, FACG, AGAF - Changing the Course of Ulcerative Colitis: Addressing Unmet Needs Through Effective Disease Severity Assessments and New Therapeutic Strategies
|
May 30, 2023 |
|
Tobias Welte, MD - Lowering the Risk of Respiratory Syncytial Virus in Older Adults: Late-Stage Emerging Vaccines
|
Apr 12, 2023 |
|
Murat Akova, MD / Jeffrey V. Lazarus, PhD, MIH, MA - Region-Specific, Patient-Centered Strategies for Optimizing Uptake of mRNA-Based COVID-19 Vaccination
|
Apr 10, 2023 |
|
Christine E. Jones, BMBS, PhD - Preventing Congenital Cytomegalovirus Through Behavioral and Emerging Vaccination Strategies
|
Mar 27, 2023 |
|
Brian S. Kim, MD - Scratching the Itch: Biologic Breakthroughs in Prurigo Nodularis
|
Mar 16, 2023 |
|
Bruce E. Strober, MD, PhD - Patient Conversations in Plaque Psoriasis: Discussing Novel TYK2 Inhibitors for the Treatment of Patients Who Are Candidates for Systemic Therapy
|
Mar 16, 2023 |
|
Marc E. Rothenberg, MD, PhD - Closing In on Improved Quality of Life for Patients With Eosinophilic Esophagitis by Targeting Type 2 Inflammation
|
Jan 09, 2023 |
|
Charles Pritchard, MD, FACR, RhMSUS - Bringing Emerging Therapies Into Motion for Non-Radiographic Axial Spondyloarthritis
|
Jan 04, 2023 |
|
Ellen J Scherl, MD - High Hopes for Emerging Small Molecules: Looking Ahead to Expanded Treatment Options for Moderate-to-Severe Crohn's Disease
|
Jan 04, 2023 |
|
Anne O'Donnell, MD - Diagnostic Imaging in Non-Cystic Fibrosis Bronchiectasis: The Radiologist's Role in Optimizing Care
|
Dec 29, 2022 |
|
Theresa W. Guilbert, MD, MS - Blazing a Trail to Enhanced Outcomes for Children with Moderate-to-Severe Asthma: Practical Strategies to Incorporate Biologics
|
Dec 02, 2022 |
|
Matteo Bonini, MD, PhD - Maximizing Outcomes With Biologics: Gaining Control Over Uncontrolled Moderate-to-Severe Asthma in Children
|
Dec 02, 2022 |
|
Sandy Durrani, MD - Enhancing Control, Maximizing Outcomes: Advancements in Care for Children With Inadequately Controlled Asthma
|
Nov 28, 2022 |
|
Latanya Benjamin, MD, FAAD, FAAP - Improving the Care of Children with Moderate-to-Severe Atopic Dermatitis: When and How to Intensify Treatment with Novel Systemic Agents
|
Nov 16, 2022 |
|
LJ Tan, MS, PhD - RSV Vaccines in Older Adults: Emerging Prevention Strategies
|
Oct 28, 2022 |
|
George Kassianos, CBE, MD (Hons), FRCGP - A Vaccinator’s Guide to Viral Vector–Based COVID-19 Vaccines
|
Sep 02, 2022 |
|
Davey Smith, MD, MAS - At the Forefront of Therapy for COVID-19: Early Identification and Treatment of Outpatients at Higher Risk of Progression to Severe Illness
|
Aug 25, 2022 |